- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
CAR-T Therapies in Solid Tumors: Opportunities and Challenges ; volume:25 ; number:5 ; day:28 ; month:2 ; year:2023 ; pages:479-489 ; date:5.2023
Current oncology reports ; 25, Heft 5 (28.2.2023), 479-489, 5.2023
- Creator
-
Guzman, Grace
Reed, Megan R.
Bielamowicz, Kevin
Koss, Brian
Rodriguez, Analiz
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11912-023-01380-x
- URN
-
urn:nbn:de:101:1-2023082911053125731698
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Guzman, Grace
- Reed, Megan R.
- Bielamowicz, Kevin
- Koss, Brian
- Rodriguez, Analiz
- SpringerLink (Online service)
Other Objects (12)
CAR-T cell combination therapies in hematologic malignancies
CAR-T Cell Therapy for Solid Tumors
Non‐BCMA targeted CAR‐T cell therapies for multiple myeloma
Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond
Engineering CAR-T cells
CAR-T cells: the long and winding road to solid tumors
Barriers to Chimeric Antigen Receptor T-Cell (CAR-T) Therapies in Clinical Practice
Availability and financing of CAR-T cell therapies: A cross-country comparative analysis
Disparities in Clinical Trial Enrollment– Focus on CAR-T and Bispecific Antibody Therapies
Complete spectrum of adverse events associated with chimeric antigen receptor (CAR)-T cell therapies
CAR-T cell combination therapies in hematologic malignancies
CAR-T Cell Therapy for Solid Tumors
Non‐BCMA targeted CAR‐T cell therapies for multiple myeloma
Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond
Engineering CAR-T cells
CAR-T cells: the long and winding road to solid tumors
Barriers to Chimeric Antigen Receptor T-Cell (CAR-T) Therapies in Clinical Practice
Availability and financing of CAR-T cell therapies: A cross-country comparative analysis
Disparities in Clinical Trial Enrollment– Focus on CAR-T and Bispecific Antibody Therapies
Complete spectrum of adverse events associated with chimeric antigen receptor (CAR)-T cell therapies
CAR-T cell combination therapies in hematologic malignancies
CAR-T Cell Therapy for Solid Tumors
Non‐BCMA targeted CAR‐T cell therapies for multiple myeloma
Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond
Engineering CAR-T cells
CAR-T cells: the long and winding road to solid tumors
Barriers to Chimeric Antigen Receptor T-Cell (CAR-T) Therapies in Clinical Practice
Availability and financing of CAR-T cell therapies: A cross-country comparative analysis
Disparities in Clinical Trial Enrollment– Focus on CAR-T and Bispecific Antibody Therapies